Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis).

Rakha EA, El-Sayed ME, Reed J, Lee AH, Evans AJ, Ellis IO.

Eur J Cancer. 2009 May;45(7):1162-7. doi: 10.1016/j.ejca.2008.12.002. Epub 2009 Jan 2.

PMID:
19121932
2.

Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses.

Rakha EA, Lee AH, Reed J, Murphy A, El-Sayed M, Burrell H, Evans AJ, Ellis IO.

Eur J Cancer. 2010 Jul;46(10):1835-40. doi: 10.1016/j.ejca.2010.03.024. Epub 2010 Apr 12.

PMID:
20392631
3.

Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.

El-Sayed ME, Rakha EA, Reed J, Lee AH, Evans AJ, Ellis IO.

Histopathology. 2008 Dec;53(6):650-7. doi: 10.1111/j.1365-2559.2008.03158.x.

PMID:
19076681
4.

Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.

Hayes BD, O'Doherty A, Quinn CM.

J Clin Pathol. 2009 Dec;62(12):1136-40. doi: 10.1136/jcp.2009.067280.

PMID:
19946101
5.

Vacuum assisted stereotactic guided mammotome biopsies in the management of screen detected microcalcifications: experience of a large breast screening centre.

Kumaroswamy V, Liston J, Shaaban AM.

J Clin Pathol. 2008 Jun;61(6):766-9. doi: 10.1136/jcp.2007.054130. Epub 2008 Mar 6.

PMID:
18326021
6.

Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.

Dillon MF, McDermott EW, Hill AD, O'Doherty A, O'Higgins N, Quinn CM.

Ann Surg Oncol. 2007 Feb;14(2):704-11. Epub 2006 Dec 7.

PMID:
17151788
7.

Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.

Carder PJ, Garvican J, Haigh I, Liston JC.

Histopathology. 2005 Mar;46(3):320-7.

PMID:
15720418
8.

Audit of performance of needle core biopsy diagnoses of screen detected breast lesions.

El-Sayed ME, Rakha EA, Reed J, Lee AH, Evans AJ, Ellis IO.

Eur J Cancer. 2008 Nov;44(17):2580-6. doi: 10.1016/j.ejca.2008.05.024. Epub 2008 Jul 14.

PMID:
18632261
9.

The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions.

Ibrahim AE, Bateman AC, Theaker JM, Low JL, Addis B, Tidbury P, Rubin C, Briley M, Royle GT.

J Clin Pathol. 2001 Feb;54(2):121-5.

10.

Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.

Rakha EA, Lee AH, Jenkins JA, Murphy AE, Hamilton LJ, Ellis IO.

Int J Cancer. 2011 Sep 15;129(6):1417-24. doi: 10.1002/ijc.25801. Epub 2011 Feb 11.

11.

[Non-palpable breast cancer malignant on needle core biopsy and no malignancy in surgical excision: how to manage?].

Cheurfa N, Giard S.

Gynecol Obstet Fertil. 2015 Jan;43(1):18-24. doi: 10.1016/j.gyobfe.2014.11.001. Epub 2014 Nov 6. French.

PMID:
25483145
12.

Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).

Lee AH, Denley HE, Pinder SE, Ellis IO, Elston CW, Vujovic P, Macmillan RD, Evans AJ; Nottingham Breast Team.

Histopathology. 2003 Apr;42(4):331-6.

PMID:
12653944
13.
14.

Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities.

White RR, Halperin TJ, Olson JA Jr, Soo MS, Bentley RC, Seigler HF.

Ann Surg. 2001 Jun;233(6):769-77.

15.

Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).

Kluttig A, Trocchi P, Heinig A, Holzhausen HJ, Taege C, Hauptmann S, Boecker W, Decker T, Loening T, Schmidt-Pokrzywniak A, Thomssen C, Lantzsch T, Buchmann J, Stang A.

BMC Cancer. 2007 Jun 14;7:100.

16.

Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.

Rakha EA, Ho BC, Naik V, Sen S, Hamilton LJ, Hodi Z, Ellis IO, Lee AH.

Histopathology. 2011 Mar;58(4):626-32. doi: 10.1111/j.1365-2559.2011.03786.x. Epub 2011 Mar 3.

PMID:
21371081
17.

Diagnostic concordance in reporting breast needle core biopsies using the B classification-A panel in Italy.

Bianchi S, Caini S, Cattani MG, Vezzosi V, Biancalani M, Palli D.

Pathol Oncol Res. 2009 Dec;15(4):725-32. doi: 10.1007/s12253-009-9176-7. Epub 2009 May 17.

PMID:
19449173
19.

[The stereotaxic core breast biopsy using the Mammotome: an alternative to intraoperative examination].

Giardina C, Guerrieri AM, Ingravallo G, Serio G, Mastropasqua MG, Lomele M, Lattanzio V.

Pathologica. 2002 Aug;94(4):182-9. Italian.

PMID:
12325416
20.

Imaging-guided core needle biopsy of papillary lesions of the breast.

Rosen EL, Bentley RC, Baker JA, Soo MS.

AJR Am J Roentgenol. 2002 Nov;179(5):1185-92.

PMID:
12388496

Supplemental Content

Support Center